Saltar al contenido
  • Home
  • About Us
  • Services
  • Courses
  • News and Events
  • Contact Us
Menú
  • Home
  • About Us
  • Services
  • Courses
  • News and Events
  • Contact Us
Buscar
Cerrar este cuadro de búsqueda.

GMPs

  1. Inicio>
  2. News and Events>
  3. GMPs
Lee más sobre el artículo Plasmids and GMPs requirements

Plasmids and GMPs requirements

Today, from Revio, we would like to share with some information on the regulatory framework regarding plasmids and Good Manufacturing Practices (GMPs) to help in the development of ATMPs that…

Continuar leyendoPlasmids and GMPs requirements

Recent Posts

  • FDA Approves First Treatment for Rare Inherited Blood Disorder
  • FDA Guidance for Industry. Human Gene Therapy for Rare Disease
  • New FDA Pilot to Accelerate the Development of Rare Disease Therapies
  • FDA announces next Cellular, Tissue and Gene Therapies Advisory Committee
  • FDA’s Guideline on Human Gene Therapy for Retinal Disorders

Recent Comments

  1. EMA's 2022 Annual Report published - Reviopharma en EMA’s 2022 Highlights on Human Medicines and Advanced Therapies

Revio is a Regulatory Affairs Consultancy – Created to support biopharmaceutical companies and public institutions, working with Advanced Therapy Medicinal Products (ATMPs)

Facebook-f Twitter Pinterest Linkedin

About

Home

About Us

Services

News & Events

Contact Us

Contact

TELEPHONES

+34 656 659 636

EMAIL

regaffairs@reviopharma.com

Legal

Cookies Policy

Data Protection

Legal Notice

Privacy policy

Social Networks

Copyright © 2023 – All Right Reserved – Powered by: Headteam.marketing

×
×

Carrito